|
COPYRIGHT 2002 International Medical News Group
LAS VEGAS - One in every 100 children and 3 in every 1,000 adults given the anticonvulsant lamotrigine will develop life-threatening cutaneous eruptions, according to Dr. Adelaide A. Hebert.
Ten percent of all patients on lamotrigine will develop erythema and a maculopapular rash, usually within the first 2-8 weeks of therapy. One percent will develop Stevens-Johnson syndrome, toxic epidermal necrolysis, angioedema, and/or pruritus.
Alert your staff about this problem so that they promptly report any patient on lamotrigine (Lamictal) who complains of fever, rash,...
Read the full article for free courtesy of your local library.
|
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
